Welcome to today's episode where we dive into an exciting breakthrough from Stanford Medicine, which has discovered a naturally occurring molecule that mimics the popular weight-loss drug Ozempic but without the broad range of side effects. Researchers screened 20,000 protein-encoding genes and identified a small peptide called BRP, composed of just 12 amino acids, which seems to work specifically in the brain's hypothalamus to control appetite and metabolism. Unlike Ozempic—known for its benefits like weight loss, improved blood sugar control, and even promising effects on alcohol addiction and osteoarthritis pain, but also accompanied by side effects such as nausea, pancreatitis, and even rare vision issues—BRP targets appetite directly, offering a more focused approach. Tests in mice and minipigs showed that a single injection could reduce food intake by up to 50% in just four hours, and longer-term studies in obese mice indicated not only significant fat loss but improved glucose and insulin responsiveness. As co-author Katrin Svensson explained, “The receptors targeted by semaglutide are found in the brain but also in the gut, pancreas and other tissues,” highlighting BRP’s advantage in its selective action. With plans underway for human clinical trials, BRP could be a game changer in the treatment of obesity with fewer adverse effects.

Key Points:

• Discovery of BRP: A naturally occurring peptide that mimics semaglutide (Ozempic) but works specifically in the brain’s hypothalamus.
• Targeted Action: Unlike Ozempic, which affects multiple organs and can lead to side effects such as nausea, pancreatitis, and even vision issues, BRP’s action is confined to reducing appetite, potentially lowering risk.
• Promising Animal Trials: Single injection in mice and minipigs reduced food intake by up to 50% in four hours; 14-day daily injections in obese mice led to fat loss and better glucose tolerance.
• Expert Insight: Co-author Katrin Svensson noted, “The receptors targeted by semaglutide are found in the brain but also in the gut, pancreas and other tissues,” emphasizing BRP's selective mechanism.
• Future Prospects: Researchers are now gearing up for human clinical trials and exploring ways to extend BRP’s effects, which could revolutionize obesity treatments.
• Published Breakthrough: The research has been published in the journal Nature, marking a significant step forward in the quest for safer weight-loss solutions.

Stay tuned as we follow this developing story and explore the potential impact of BRP on the fight against obesity!
Link to Article